Increased Rate of Prophylaxis Against Venous Thromboembolism Due to eAlerts

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
University of Zurich
ClinicalTrials.gov Identifier:
NCT01598805
First received: May 11, 2012
Last updated: November 15, 2012
Last verified: November 2012
  Purpose

Now, after a cluster randomized controlled trial, eAlerts providing evidence-based guidelines on venous thromboembolism prophylaxis will be rolled out and evaluated hospital-widely.


Condition Intervention
Venous Thromboembolism
Behavioral: electronic alerts

Study Type: Interventional
Study Design: Endpoint Classification: Efficacy Study
Intervention Model: Single Group Assignment
Masking: Single Blind (Subject)
Primary Purpose: Health Services Research
Official Title: Increased Rate of Prophylaxis Against Venous Thromboembolism Due to eAlerts

Resource links provided by NLM:


Further study details as provided by University of Zurich:

Primary Outcome Measures:
  • Rate of prophylaxis against venous thromboembolism [ Time Frame: 3 months ] [ Designated as safety issue: No ]
    patients with prophylaxis/total patients


Secondary Outcome Measures:
  • ordering time after admission or transfer of a patient [ Time Frame: 3 months ] [ Designated as safety issue: No ]
    time when physicians order a venous thromboembolism prophylaxis

  • acceptance of the eAlerts [ Time Frame: 3 months ] [ Designated as safety issue: No ]
    survey of compliant and incompliant physicians


Enrollment: 10000
Study Start Date: June 2012
Study Completion Date: September 2012
Primary Completion Date: September 2012 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: roll out of eAlerts
Roll out of eAlerts providing evidence-based guidelines on prophylaxis against venous thromboembolism. An eAlert is displayed in the electronic patient chart if no prophylaxis has been ordered within 6 h after admission or transfer.
Behavioral: electronic alerts
An eAlert is displayed in the electronic patient chart if no prophylaxis has been ordered within 6 h after admission or transfer.
Other Name: eAlert

Detailed Description:

An eAlert is displayed in the electronic patient chart if no prophylaxis has been ordered within 6 h after admission or transfer. The eAlerts provide evidence-based guidelines on venous thromboembolism prophylaxis. Now, after a cluster randomized controlled trial, the eAlerts will be rolled out and evaluated hospital-widely.

  Eligibility

Ages Eligible for Study:   16 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion criteria:

  • all in-patients hospitalized in a ward with computerized physician order entry (CPOE),
  • staying at least 24 h in a ward

Exclusion criteria:

  • outpatients,
  • ward without CPOE,
  • patients transferred from an intervention to a control ward and vice versa
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01598805

Locations
Switzerland
University Hospital Zurich, Center for Clinical Research
Zurich, Switzerland
Sponsors and Collaborators
University of Zurich
Investigators
Principal Investigator: Juerg Blaser, Prof. PhD University Hospital Zurich, Center for Clinical Research, Research Center for Medical Informatics
  More Information

No publications provided

Responsible Party: University of Zurich
ClinicalTrials.gov Identifier: NCT01598805     History of Changes
Other Study ID Numbers: FZMI-KEK-ZH-Nr. 2010-0458
Study First Received: May 11, 2012
Last Updated: November 15, 2012
Health Authority: Switzerland: Ethikkommission

Keywords provided by University of Zurich:
venous thromboembolism/prevention & control

Additional relevant MeSH terms:
Thromboembolism
Venous Thromboembolism
Venous Thrombosis
Embolism and Thrombosis
Vascular Diseases
Cardiovascular Diseases
Thrombosis

ClinicalTrials.gov processed this record on April 23, 2014